ISOLAZ® 2 SYSTEM. - COFEPRIS Registration 584E2019 SSA
Access comprehensive regulatory information for ISOLAZ® 2 SYSTEM. (ISOLAZ® 2 SYSTEM.) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 584E2019 SSA and manufactured by BAUSCH & LOMB MÉXICO, S.A. DE C.V.. The device was registered on March 20, 2019.
This page provides complete registration details including product type (I. MEDICAL EQUIPMENT), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL SISTEMA ISOLAZ® 2 ESTÁ INDICADO PARA EL TRATAMIENTO DE ACNÉ LEVE A MODERADO, INCLUYENDO EL ACNÉ PUSTULOSO, EL ACNÉ COMEDÓNICO Y EL ACNÉ INFLAMATORIO LEVE A MODERADO (ACNÉ VULGAR) EN TODOS LOS TIPOS DE PIEL (I-VI EN LA CLASIFICACIÓN DE FITZPATRICK). EL
THE ISOLAZ® 2 SYSTEM IS INDICATED FOR THE TREATMENT OF MILD TO MODERATE ACNE, INCLUDING PUSTULAR ACNE, COMEDONIC ACNE AND MILD TO MODERATE INFLAMMATORY ACNE (ACNE VULGARIS) ON ALL SKIN TYPES (I-VI IN THE FITZPATRICK CLASSIFICATION). THE